Treatment‐to‐Target With Apremilast in Psoriatic Arthritis: The Probability of Achieving Targets and Comprehensive Control of Disease Manifestations

OBJECTIVE: The present study was undertaken to evaluate the probability of achieving the Clinical Disease Activity Index for Psoriatic Arthritis (cDAPSA) treatment targets of remission or low disease activity (LDA) with apremilast based on disease activity categories and corresponding responses in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mease, Philip J., Gladman, Dafna D., Ogdie, Alexis, Coates, Laura C., Behrens, Frank, Kavanaugh, Arthur, McInnes, Iain, Queiro, Rubén, Guerette, Benoit, Brunori, Michele, Teng, Lichen, Smolen, Josef S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Psoriatic Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317912/
https://www.ncbi.nlm.nih.gov/pubmed/31909868
http://dx.doi.org/10.1002/acr.24134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317912/
https://www.ncbi.nlm.nih.gov/pubmed/31909868
http://dx.doi.org/10.1002/acr.24134

Ejemplares similares